Digital Microfluidic Surfactant Segmentation for Biofouling Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Digital microfluidic devices face limitations in handling biomolecules due to biofouling and evaporation issues, particularly when dealing with proteins and nucleic acids, as surfactants in the oil layer can be detrimental and high surfactant levels in the aqueous layer affect protein-protein interactions and detection efficiency.

Innovation Solution

Incorporating a non-ionic surfactant like Pluronic F127 in the aqueous layer and a surfactant such as Span85 in the oil layer, allowing for reduced surfactant levels in the aqueous phase while maintaining effective droplet manipulation and protein expression, enabling dilution-free cell-free protein synthesis and detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If surfactant is added to the oil layer to prevent biofouling, then droplet stability is improved, but protein-protein interactions and detection efficiency deteriorate

Engineering Contradiction:
Improvedroplet stabilityVSAvoiddetection efficiency
Core Design Contradiction:
ReliabilityVSMeasurement precision

Solution Approach 1:

The system divides the surfactant application into two separate segments: a first surfactant (e.g., Pluronic F127) in the aqueous layer and a second surfactant (e.g., Span85) in the oil layer. This segmentation allows each surfactant to perform its specific function independently - the aqueous surfactant maintains protein interaction capability while the oil surfactant provides droplet stability, thereby resolving the contradiction between detection efficiency and droplet stability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different surfactant properties are applied to different locations/layers of the system. The hydrophilic first surfactant is localized in the aqueous layer where protein interactions occur, while the hydrophobic second surfactant is localized in the oil layer where droplet stability is needed. This local quality differentiation enables both protein-protein interactions and droplet stability to coexist without interference.

Inventive Principle:
Principle #3Local quality

2Ease of operation

If high concentration of surfactant is used in the aqueous layer to reduce biofouling, then droplet manipulation is improved, but protein expression consistency deteriorates

Engineering Contradiction:
Improvedroplet manipulationVSAvoidprotein expression consistency
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The surfactant function is segmented between two layers: the first surfactant in the aqueous layer at optimized concentration for protein expression, and the second surfactant in the oil layer for droplet manipulation. This segmentation allows droplet manipulation to be achieved through the oil-layer surfactant without compromising protein expression consistency in the aqueous layer.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The second surfactant in the oil layer acts as an intermediary that enables droplet manipulation without directly contacting the proteins in the aqueous layer. This intermediary approach allows droplet handling to be facilitated while keeping the protein environment clean and consistent for reliable expression.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Duration of action of moving object

If surfactant is added to enable prolonged droplet actuation, then operating duration is extended, but biofouling increases

Engineering Contradiction:
Improveactuation timeVSAvoidbiofouling
Core Design Contradiction:
Duration of action of moving objectVSObject-generated harmful factors

Solution Approach 1:

The anti-biofouling function is segmented between two surfactants in two layers. The first surfactant in the aqueous layer provides sustained biofouling protection during prolonged actuation, while the second surfactant in the oil layer provides additional protection at the oil-aqueous interface. This segmented approach extends actuation time while maintaining low biofouling levels.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system uses a composite surfactant system combining two different surfactants with complementary properties - a hydrophilic surfactant in the aqueous phase and a hydrophobic surfactant in the oil phase. This composite approach provides enhanced and sustained biofouling protection throughout the prolonged actuation period, addressing both duration extension and biofouling reduction.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the stability and movement of droplets, reduces biofouling, and improves the consistency and ease of protein expression and detection processes on digital microfluidic devices, allowing for prolonged protein synthesis and expression without dilution or adulteration.

Implementation Method 1

Electrowetting is the modification of the wetting properties of a surface (which is typically hydrophobic) with an applied electric field. Digital microfluidics utilizes alternating currents on an electrode array for moving fluid on the surface of the array by electrowetting.

Methodology Applied
Scientific EffectElectrowetting: Electrowetting

Implementation Method 2

Incorporating a non-ionic surfactant like Pluronic F127 in the aqueous layer and a surfactant such as Span85 in the oil layer, allowing for reduced surfactant levels in the aqueous phase while maintaining effective droplet manipulation and protein expression.

Methodology Applied
Scientific EffectSurfactant: Surfactant

Data Source

PatentUS20240359181A1Methods and compositions for improved biomolecule assays on digital microfluidic devices
Publication Date: 2024.10.31 NUCLERA LTD
  • US20240359181A1 patent drawing
  • US20240359181A1 patent drawing
  • US20240359181A1 patent drawing

AI summary

Provided herein are methods, and compositions for the detection and analysis of biomolecule interactions a microfluidic device. The detection and analysis occurs in aqueous droplets having a first surfactant within an oil layer having a second surfactant.